… cardiac effects of the tricyclic antidepressants (TCAs) have been well characterized. In contrast,
the cardiac effects of the selective serotonin reuptake inhibitors (… reports of cardiac effects …

… function as safe and efficacious agents against depression, platelet … of coronary artery disease
and congestive heart failure. … serotonin reuptake inhibitors in patients with depression and …

… with comorbid ischemic heart disease (IHD), the cardiovascular … the safety of various
antidepressant classes, specifically the tricyclics and selective serotonin reuptake inhibitors (SSRIs) …

… of ischemic heart disease (IHD) and poor prognosis of patients … depression treatment, selective
serotonin reuptake inhibitors (… as well as the cardiac safety of sertraline hydrochloride for …

… (TCAs), selective serotonin reuptake inhibitors (SSRIs), and … depression in the patient with
ischemic heart disease (IHD), … proven to be safe and effective for depression in patients with …

… Among the novel risk factors in coronary artery disease (CAD) patients, the importance of
depression has been … After the safety of one of the SSRIs (fluoxetine) in depressed patients with …

… Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment
of melancholia. Am J Psychiatry 1994; 151: 1735-9 25. Zielinski, RJ, Roose SP, Devanand …

… in patients with or without known coronary artery disease (CAD). Treatment of depression
has … serotonin reuptake inhibitor (SSRI) in patients with CVD, nortriptyline had more adverse …

… of cardiac toxicity, even in patients with stable heart disease. However, no data on the safety
… study are readily observable in patients with stable coronary artery disease remains to be …

… in patients, not only with depression, but with coronary artery disease, and ischemic stroke
… Future strategies in patients after vascular events must consider combined safe approaches …